The Federal Trade Commission is launching a probe into recent shortages of chemotherapies and other drugs, examining the role played by companies that help buy and distribute the bulk of medicines sold to U.S. hospitals.
The inquiry shines a spotlight on a little-noticed corner of the drug supply chain—but one that can have an outsize impact on stores of critical medicines.
Top 10 Most Popular Men’s Luxury Watches to Invest In 2026
Discover the most popular men’s luxury watches to invest in for 2026. Find timeless timepieces with proven resale value for savvy collectors.
